Editorial: News in Graves’ orbitopathy: patients management and treatments

Editorial: News in Graves’ orbitopathy: patients management and treatments

Bibliographic Details
Main Authors:	Giulia Lanzolla, Elena Sabini
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Series:	Frontiers in Endocrinology
Subjects:	Graves’ disease (GD) thyroid autoimmunity thyroid eye disease (TED) Graves’ orbitopathy thyroid thyroid disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1270467/full

Similar Items

Rituximab in the treatment of Graves’ orbitopathy: latest updates and perspectives
by: Jakub Supronik, et al.
Published: (2022-11-01)

How Age Affects Graves’ Orbitopathy—A Tertiary Center Study
by: Michael Oeverhaus, et al.
Published: (2024-01-01)

Influence of biological sex, age and smoking on Graves’ orbitopathy – a ten-year tertiary referral center analysis
by: Michael Oeverhaus, et al.
Published: (2023-04-01)

Effectiveness of educational materials on levels of knowledge of thyroid associated orbitopathy in an endocrinology clinic
by: Wajiha J. Kheir, et al.
Published: (2023-12-01)

Thyroid Receptor Antibody and the Development of Graves’ Orbitopathy: Clinical Experience of using Radioiodine Ablation in the Management of Graves’ Orbitopathy in post-iodine ablation hypothyroid patient
by: Edelyn Christina, et al.
Published: (2023-06-01)

Microbiota Alterations in Patients with Autoimmune Thyroid Diseases: A Systematic Review
by: Nadia Sawicka-Gutaj, et al.
Published: (2022-11-01)

Emerging therapies in the medical management of thyroid eye disease
by: Alisha Kamboj, et al.
Published: (2023-12-01)

Selenium supplements: is it advisable to use them in treatment of pathology of the thyroid gland?
by: V. Katerenchuk, et al.
Published: (2022-04-01)

Thyroid Eye Disease
by: Ramy Rashad, et al.
Published: (2022-12-01)

Significance of thyroperoxidase and thyroglobulin antibodies in medically treated Graves’ disease
by: Stefan Matei Constantinescu, et al.
Published: (2023-12-01)

Autoimmune Thyroiditis Shifting from Hashimoto’s Thyroiditis to Graves’ Disease
by: Narantsatsral Daramjav, et al.
Published: (2023-04-01)

Orbital Inflammation in Thyroid Eye Disease: Stress Responses and Their Implications
by: Tracy Aoun, et al.
Published: (2024-01-01)

Tocilizumab improves clinical outcome in patients with active corticosteroid-resistant moderate-to-severe Graves’ orbitopathy: an observational study
by: Georgios Boutzios, et al.
Published: (2023-06-01)

A Comparison of Observational Studies on Subfoveal Choroidal Thickness Measured with OCT according to the Level of Thyroid Eye Disease Activity—Systematic Review and Meta-Analysis
by: Małgorzata Kowalik-Jagodzińska, et al.
Published: (2023-07-01)

Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease
by: Anne Gulbins, et al.
Published: (2023-06-01)

Autoimmune thyroid disease: Case reports of two siblings
by: Chikezie Hart Onwukwe, et al.
Published: (2023-01-01)

The association of race with thyroid eye disease presentation and outcomes
by: Diane Wang, et al.
Published: (2024-01-01)

A Graves' Disease Patient Diagnosed as Autoimmune Gastritis with Helicobacter pylori Infection
by: Yong Hwan Ahn, et al.
Published: (2022-12-01)

Current imaging methods for assessing Graves` orbitopathy activity with particular emphasis on FDG-PET
by: Anna Ochmann, et al.
Published: (2023-08-01)

Morphological features of thyroid benign focal neoplasms in Graves’ disease
by: Yu.V. Buldygina, et al.
Published: (2022-06-01)

Potential involvement of the bone marrow in experimental Graves’ disease and thyroid eye disease
by: Anne Gulbins, et al.
Published: (2023-09-01)

Acute suppurative thyroiditis with Graves disease – A very rare association
by: Inês Damásio, et al.
Published: (2023-06-01)

Application of artificial intelligence in the assessment of thyroid eye disease (TED) - a scoping review
by: Chiaw-Ling Chng, et al.
Published: (2023-12-01)

Are severe forms of thyroid eye disease common in the indian population? Clinical characteristics of 136 patients from a tertiary eye care centre
by: Dhakshini L Subramaniam, et al.
Published: (2023-01-01)

SELENIUM AND AUTOIMMUNE THYROIDITIS
by: Marco Giammanco
Published: (2023-04-01)

Magnetic resonance imaging parameters on lacrimal gland in thyroid eye disease: a systematic review and meta-analysis
by: Nicole Tsz Yan Wong, et al.
Published: (2023-08-01)

Commentary: Azathioprine as an adjuvant therapy in severe Graves’ disease: a randomized controlled open-label clinical trial
by: Madhukar Mittal, et al.
Published: (2024-02-01)

Characteristics of Optic Disc and Visual Field Changes in Patients with Thyroid-Associated Orbitopathy and Open-Angle Glaucoma
by: Chih-Kang Hsu, et al.
Published: (2021-08-01)

Usefulness of Functional Thyroid-Stimulating and Thyroid-Blocking Immunoglobulin Bioassays in an Atypical Presentation of Graves’ Disease
by: Julie Sherfan, MScMed, MAACB, et al.
Published: (2023-05-01)

Sphingolipids in thyroid eye disease
by: Anne Gulbins, et al.
Published: (2023-04-01)

A Tear Metabolomic Profile Showing Increased Ornithine Decarboxylase Activity and Spermine Synthesis in Thyroid-Associated Orbitopathy
by: Benjamin Billiet, et al.
Published: (2022-01-01)

Steroid-resistant Graves' orbitopathy: Therapeutic options
by: Klet Sanja, et al.
Published: (2023-01-01)

Efficacy and Safety of 6-Weekly versus 12-Weekly Intravenous Methylprednisolone in Moderate-to-Severe Active Thyroid-Associated Ophthalmopathy
by: Kenneth K. H. Lai, et al.
Published: (2023-05-01)

How patients experience thyroid eye disease
by: Terry J. Smith, et al.
Published: (2023-11-01)

Long-term outcomes of inferomedial orbital wall decompression in Graves' ophthalmopathy in an Asian population: A 30-year retrospective study
by: Chu-Ying Chung, et al.
Published: (2024-01-01)

Current Knowledge on Graves’ Orbitopathy
by: Katarzyna Gontarz-Nowak, et al.
Published: (2020-12-01)

A Mendelian randomization study of the effect of serum 25-hydroxyvitamin D levels on autoimmune thyroid disease
by: Yunfeng Yu, et al.
Published: (2024-01-01)

The role of Graves’ disease in the development of thyroid nodules and thyroid cancer
by: Marta Nascimento Soares, et al.
Published: (2023-07-01)

Anti-IL-6 Receptor Tocilizumab in Refractory Graves’ Orbitopathy: National Multicenter Observational Study of 48 Patients
by: Lara Sánchez-Bilbao, et al.
Published: (2020-08-01)

Traumatic Orbital Floor Fracture Causing Therapeutic Orbital Decompression in Thyroid Eye Disease
by: Patrick Buoniconti, et al.
Published: (2022-12-01)